Chemicals & Advanced Materials Global On demand · 24-48h

Global Cannabidiol Oil (CBD Oil) Market Strategic Research Report

Global Cannabidiol Oil (CBD Oil) Market Strategic Research R…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Cannabidiol Oil (CBD Oil) Market
$1.11B2025
18.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Hemp-derived, Marijuana-derived

By Application: Pharmaceuticals, Food, Cosmetics, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Kazmira, CV Sciences, Charlotte's Web, Freedom Leaf, Green Road, Folium Biosciences, HempLife Today, Pharma Hemp, Endoca, CBD American Shaman, NuLeaf Naturals, Select Oil, Village Farms, Canopy Growth Corporation, SNDL, Tilray, Emblem Cannabis Oils, The Lab, British Cannabis, Cornbread Hemp

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 130 pages
Market size 2025
$1.11B
Billion USD
Forecast CAGR
18.8%
2025-2032
Forecast 2032
$3.7B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Cannabidiol Oil (CBD Oil) market size is predicted to grow from US$ 1,110 million in 2025 to US$ 3,670 million in 2032; it is expected to grow at a CAGR of 18.8% from 2026 to 2032.

Cannabidiol (CBD) oil is a natural botanical concentrate derived from the cannabis plant, rich in the compound cannabidiol (CBD). Among the more than 85 cannabinoids identified in cannabis, CBD is the second most prevalent after tetrahydrocannabinol (THC). Unlike THC, CBD is non-psychoactive and is widely used for its potential therapeutic benefits, including relief from anxiety, inflammation, and epilepsy.

Global Cannabidiol Oil (CBD Oil) main players are Kazmira, HempLife Today, Cannavest, Pharmahemp, ENDOCA, etc. Global top four manufacturers hold a share over 35%. North America is the largest market, with a share over 50%.The cannabidiol (CBD) oil market has experienced rapid growth, particularly in North America, Europe, and select parts of Asia, driven by rising consumer interest in non-psychoactive, plant-based health products. Regulatory liberalization in various regions has opened the door for both established companies (e.g., Charlotte’s Web, CV Sciences) and emerging startups. The upstream supply chain depends heavily on industrial hemp cultivation with high-CBD strains, while midstream involves technologically intensive extraction processes, such as supercritical CO₂ extraction. Downstream, CBD oil is widely applied in oral tinctures, softgels, topicals, and even pet wellness products. Future market drivers include increasing regulatory clarity, scientific validation of health benefits, standardization of product quality, and the expansion of global distribution networks. However, legal uncertainty in several jurisdictions and continued consumer education remain key barriers to broader market penetration.

This report presents a comprehensive overview of the global Cannabidiol Oil (CBD Oil) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Hemp-derived
  • Marijuana-derived

Segment by Application

  • Pharmaceuticals
  • Food
  • Cosmetics
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Cannabidiol Oil (CBD Oil) market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmaceuticals, Food, Cosmetics evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Cannabidiol Oil (CBD Oil) Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 18.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.11B
2025
Forecast
$3.7B
2032
CAGR
18.8%
2025–2032
Regions
5
global
Key companies
KazmiraCV SciencesCharlotte's WebFreedom LeafGreen RoadFolium BiosciencesHempLife TodayPharma Hemp
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Hemp-derivedMarijuana-derived
By Application
PharmaceuticalsFoodCosmeticsOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Hemp-derived
  • 3.1.3 Marijuana-derived
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmaceuticals
  • 4.1.3 Food
  • 4.1.4 Cosmetics
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Kazmira
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 CV Sciences
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Charlotte's Web
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Freedom Leaf
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Green Road
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Folium Biosciences
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 HempLife Today
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Pharma Hemp
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Endoca
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 CBD American Shaman
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 NuLeaf Naturals
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Select Oil
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Village Farms
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Canopy Growth Corporation
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 SNDL
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Tilray
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Emblem Cannabis Oils
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 The Lab
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 British Cannabis
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Cornbread Hemp
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Cannabidiol Oil (CBD Oil) market size?
The global Cannabidiol Oil (CBD Oil) market is estimated at US$ 1.11 billion in 2025 (base year) and is projected to reach US$ 3.67 billion by 2032.
What growth rate is expected for the Cannabidiol Oil (CBD Oil) market through 2032?
The market is expected to grow at a CAGR of 18.8% from 2026 to 2032, expanding from US$ 1.11 billion in 2025 to US$ 3.67 billion in 2032, roughly 3.3 times its base-year value.
How is Cannabidiol Oil (CBD Oil) defined?
Cannabidiol (CBD) oil is a natural botanical concentrate derived from the cannabis plant, rich in the compound cannabidiol (CBD). Among the more than 85 cannabinoids identified in cannabis, CBD is the second most prevalent after tetrahydrocannabinol (THC). Unlike THC, CBD is non-psychoactive and is widely used for its potential therapeutic benefits, including relief from anxiety, inflammation, and epilepsy.
What are the main segments of the Cannabidiol Oil (CBD Oil) market by type?
By type, the market is segmented into Hemp-derived and Marijuana-derived.
Which applications drive demand in the Cannabidiol Oil (CBD Oil) market?
Key applications covered include Pharmaceuticals, Food, Cosmetics and Other.
Who are the key players in the Cannabidiol Oil (CBD Oil) market?
Key players profiled include Kazmira, CV Sciences, Charlotte's Web, Freedom Leaf, Green Road, Folium Biosciences, HempLife Today and Pharma Hemp, among 20 companies covered in total.
Which regions and countries are covered for Cannabidiol Oil (CBD Oil)?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Cannabidiol Oil (CBD Oil) market?
North America is the largest market, with a share over 50%.The cannabidiol (CBD) oil market has experienced rapid growth, particularly in North America, Europe, and select parts of Asia, driven by rising consumer interest in non-psychoactive, plant-based health products.
What challenges does the Cannabidiol Oil (CBD Oil) market face?
However, legal uncertainty in several jurisdictions and continued consumer education remain key barriers to broader market penetration.
Who should buy the Cannabidiol Oil (CBD Oil) market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceuticals, Food and Cosmetics, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Cannabidiol Oil (CBD Oil) market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.